Drugmakers should disclose U.S. doctor perks: experts
234856
Drugmakers vying to entice physicians to use their products with trips to exotic locales and other perks should be required to disclose such gifts, experts told a congressional panel on Wednesday.
188471
Drug manufacturers acknowledged Thursday that they face a crisis of credibility they hope to remedy by releasing information about their clinical trials.
362519
Health regulators on Friday issued draft guidance that would make it easier for pharmaceutical companies to advise doctors about unapproved uses for their medicines.
233956
Some states are paying far higher prices than others for prescription drugs under the Medicaid program, but data that would help them get a better deal are kept confidential by the federal government, a new report says.
685810
NEW YORK  - Physicians frequently fail to   provide patients with all the information they should have when   they're prescribed new medication, investigators in California   report.
333292
Last Thursday, the day the Food and Drug Administration launched a two-day advisory panel on the risks of drug-coated stents, doctors across the country found an e-mail on their computers from stent maker Johnson &amp; Johnson, inviting them to join a conference call about stent safety.
592264
The drug industry, fighting off criticism for hiding data from negative studies, unveiled on Tuesday a database for firms to voluntarily provide summarized results of most clinical trials of medicines sold in the United States.
712345
Physicians frequently fail to  provide patients with all the information they should have when  they're prescribed new medication, investigators in California  report.
341332
A month after a new U.S. law  encouraging the development of medicines to counter  bioterrorism, some drugmakers are lobbying for more incentives  to make products that may never be used.
721660
NEW YORK  - Physicians frequently disclose information about themselves to patients, new research shows, and contrary to what some researchers believe, this does not enhance the doctor-patient relationship and may actually be disruptive.
91514
A veteran U.S. Food and Drug  Administration scientist will unveil new data on Thursday  before an expert panel charged with determining whether pain  relievers similar to Merck & Co. Inc.'s now-withdrawn Vioxx  should remain on the market.
71373
Washington -- The government should reassess its policy of allowing prescription drugs to be advertised directly to consumers, a prominent cardiologist urged Tuesday in the Journal of the American Medical Association.
282668
Medical researchers said the U.S. needs a system independent of the F.D.A. to detect harmful effects of drugs already on the market.
296838
Federal health officials said Thursday they would ask outside experts whether the benefits of an antibiotic linked to rare reports of severe liver problems, including several deaths, outweigh its benefits.
337275
BusinessWeek Online - The news last week that GlaxoSmithKline&#39;s  popular diabetes drug Avandia may increase the risk of heart attacks is now causing a rift among doctors by specialty, leading to charges by each side that the other is endangering patients. Endocrinologists, who treat diabetics, tend to regard the data, which was published in The New England Journal of Medicine, with skepticism, pointing to weaknesses in the study, particularly when compared to more rigorous clinical trials. Cardiologists and drug safety experts, foremost among them study author Dr. ...
4655
Drugmaker Eli Lilly and Co.  on Wednesday said it will make clinical trial information available online amid calls by lawmakers and physicians for more disclosure of negative trial results.
570747
More patients with serious diseases could get experimental drugs under revised rules proposed on Monday by the U.S. Food and Drug Administration that also detail how manufacturers can charge for them.